Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	514.94	233.89	-38.03
Graham Fair Price	-74.57	1.94	7.63
PEG	27651.32	-0.94	< 0.005
Price/Book	-18.55	2.96	3.64
Price/Cash Flow	115.02	364.16	-169.36
Prices/Earnings	1178.89	100.04	-7.82
Price/Sales	-18.54	8.97	11.01
Price/FCF	115.02	364.16	-169.36
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-26.22	0.07	0.10
Operating Margin	-65.26	0.04	-0.11
ROA	-93.97	< 0.005	-0.07
ROE	-0.12	< 0.005	-93.63
ROIC	-0.02	< 0.005	-66.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.19	< 0.005	2606.86
Dividends QOQ	2.31	-0.80	-65.60
EBIT QOQ	-4.56	1.35	-70.38
EPS QOQ	-23.09	1.06	-95.39
FCF QOQ	-4.74	1.38	-70.83
Revenue QOQ	-0.03	< 0.005	-73.71
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.28	66.36	43.39
Days Sales Outstanding (DSO)	189.95	179.08	-5.72
Inventory Turnover	1.94	1.36	-30.26
Debt/Capitalization	0.24	0.28	13.29
Quick Ratio	2.38	1.92	-19.33
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.72	4.76	0.75
Cash	1.58	1.67	6.25
Capex	< 0.005	< 0.005	-460.43
Free Cash Flow	-0.10	0.04	-61.84
Revenue	1.56	1.57	0.74
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.79	2.48	-10.85
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.09	2.50	2593.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating